Ami Fadia
Stock Analyst at Needham
(4.03)
# 576
Out of 5,024 analysts
394
Total ratings
47.91%
Success rate
12.85%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Initiates: Buy | $19 | $14.52 | +30.85% | 1 | Oct 13, 2025 | |
| ATAI Atai Life Sciences | Initiates: Buy | $12 | $5.96 | +101.34% | 1 | Oct 13, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $28 | $12.66 | +121.17% | 1 | Oct 13, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $11 | $6.16 | +78.57% | 20 | Sep 30, 2025 | |
| MRUS Merus | Downgrades: Hold | $96 | $94.95 | +1.11% | 31 | Sep 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $30 → $28 | $21.74 | +28.79% | 11 | Sep 24, 2025 | |
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $48 → $41 | $26.63 | +53.96% | 38 | Sep 24, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $143.66 | - | 43 | Sep 24, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $161 → $170 | $137.73 | +23.43% | 15 | Sep 22, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $56 → $66 | $49.56 | +33.17% | 26 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $135.80 | +48.75% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $16 | $7.78 | +105.66% | 21 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $129.58 | +15.76% | 16 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $32.23 | +39.62% | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $16.57 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $57.35 | +39.49% | 12 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.59 | +54.94% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.84 | +171.74% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $15.16 | +25.33% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $8.39 | +245.65% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $19.92 | +1,506.43% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.45 | +219.83% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.74 | +2,950.02% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $21.38 | +194.67% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $19.78 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.35 | +1,535.69% | 4 | Jan 3, 2018 |
GH Research
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $14.52
Upside: +30.85%
Atai Life Sciences
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $5.96
Upside: +101.34%
Mind Medicine (MindMed)
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.66
Upside: +121.17%
Immuneering
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.16
Upside: +78.57%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $94.95
Upside: +1.11%
ACADIA Pharmaceuticals
Sep 24, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $21.74
Upside: +28.79%
Harmony Biosciences Holdings
Sep 24, 2025
Maintains: Buy
Price Target: $48 → $41
Current: $26.63
Upside: +53.96%
Biogen
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $143.66
Upside: -
Neurocrine Biosciences
Sep 22, 2025
Maintains: Buy
Price Target: $161 → $170
Current: $137.73
Upside: +23.43%
Revolution Medicines
Sep 11, 2025
Maintains: Buy
Price Target: $56 → $66
Current: $49.56
Upside: +33.17%
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $135.80
Upside: +48.75%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $7.78
Upside: +105.66%
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $129.58
Upside: +15.76%
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $32.23
Upside: +39.62%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $16.57
Upside: -
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $57.35
Upside: +39.49%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $22.59
Upside: +54.94%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.84
Upside: +171.74%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $15.16
Upside: +25.33%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.39
Upside: +245.65%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $19.92
Upside: +1,506.43%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.45
Upside: +219.83%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.74
Upside: +2,950.02%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $21.38
Upside: +194.67%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $19.78
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.35
Upside: +1,535.69%